[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors; TNG462, which is in Phase 1/2 clinical trial for non- central nervous system cancers including pancreatic and lung cancer; TNG456, a brain-penetrant PRMT5 inhibitor, for central nervous system cancers including glioblastoma; and TNG260, a co-repressor of repressor element-1 silencing transcription (CoREST) inhibitor to reverse the immune evasion effect of STK11 loss-of-function mutations. The company has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1039811, "exercisedValue": 0, "unexercisedValue": 9991192}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 977216, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Ashworth FRS, Ph.D.", "age": 62, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 56, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy  Redfern", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth Pingpank Hickin", "title": "VP of IR & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.27, "open": 1.27, "dayLow": 1.21, "dayHigh": 1.32, "regularMarketPreviousClose": 1.27, "regularMarketOpen": 1.27, "regularMarketDayLow": 1.21, "regularMarketDayHigh": 1.32, "payoutRatio": 0.0, "beta": 1.033, "forwardPE": -0.8943662, "volume": 698760, "regularMarketVolume": 698760, "averageVolume": 792133, "averageVolume10days": 861640, "averageDailyVolume10Day": 861640, "bid": 1.23, "ask": 1.29, "bidSize": 1, "askSize": 1, "marketCap": 137297152, "fiftyTwoWeekLow": 1.21, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 3.2636182, "fiftyDayAverage": 2.2103, "twoHundredDayAverage": 5.675125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -84126976, "profitMargins": 0.0, "floatShares": 46645311, "sharesOutstanding": 108108000, "sharesShort": 9113933, "sharesShortPriorMonth": 5942526, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.084300004, "heldPercentInsiders": 0.08397, "heldPercentInstitutions": 0.99496, "shortRatio": 11.15, "shortPercentOfFloat": 0.1545, "impliedSharesOutstanding": 108108000, "bookValue": 1.852, "priceToBook": 0.6857451, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -130302000, "trailingEps": -1.19, "forwardEps": -1.42, "enterpriseToRevenue": -2.0, "enterpriseToEbitda": 0.588, "52WeekChange": -0.82907134, "SandP52WeekChange": -0.024663687, "quoteType": "EQUITY", "currentPrice": 1.27, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.0, "targetMedianPrice": 10.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 257916992, "totalCashPerShare": 2.386, "ebitda": -143096000, "totalDebt": 36493000, "quickRatio": 6.757, "currentRatio": 6.978, "totalRevenue": 42069000, "debtToEquity": 18.291, "revenuePerShare": 0.385, "returnOnAssets": -0.2531, "returnOnEquity": -0.57576, "grossProfits": -101849000, "freeCashflow": -67267872, "operatingCashflow": -131501000, "revenueGrowth": -0.242, "grossMargins": -2.421, "ebitdaMargins": 0.0, "operatingMargins": -9.93685, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tango Therapeutics, Inc.", "longName": "Tango Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1743804364, "regularMarketTime": 1743796802, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.27, "postMarketChangePercent": -0.787401, "postMarketPrice": 1.26, "postMarketChange": -0.00999999, "regularMarketChange": 0.0, "regularMarketDayRange": "1.21 - 1.32", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 792133, "fiftyTwoWeekLowChange": 0.059999943, "fiftyTwoWeekLowChangePercent": 0.04958673, "fiftyTwoWeekRange": "1.21 - 12.015", "fiftyTwoWeekHighChange": -10.745001, "fiftyTwoWeekHighChangePercent": -0.89429885, "fiftyTwoWeekChangePercent": -82.907135, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.42, "epsCurrentYear": -1.30238, "priceEpsCurrentYear": -0.9751378, "fiftyDayAverageChange": -0.9403, "fiftyDayAverageChangePercent": -0.42541736, "twoHundredDayAverageChange": -4.405125, "twoHundredDayAverageChangePercent": -0.7762164, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "marketState": "CLOSED", "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-05"}]